Saturday 17 October 2026
Export DCGO’s income statement to Excel — free account
DocGo Inc.
DCGO Healthcare Medical Care Facilities
DocGo Inc.’s revenue for fiscal 2025 (year ended December 2025) was $322.2 million, down 47.7% from fiscal 2024. In the quarter to June 2026, revenue fell 8.70%, EPS fell 45.5%, free cash flow fell 132.3% and total debt rose 7,140.9%, each against the same quarter a year earlier.
0.27
0.01
−3.57%
Follow DCGO
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '17 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 8 | 3 | 4 | — | — | — |
P/E ratio |
0.00 | 22.32 | 73.86 | 20.53 | 7.10 | 0.00 | — |
P/S ratio |
0.27 | 0.70 | 0.86 | 1.70 | 2.36 | 0.00 | — |
Altman Z-Score |
(1.37) | 3.89 | 3.60 | 5.48 | 7.13 | 10.36 | — |
Altman Z″-Score (non-manufacturers) |
(4.26) | 5.40 | 4.05 | 5.55 | 6.75 | 0.57 | — |
P/FCF ratio |
3.20 | 6.70 | 0.00 | 32.00 | 0.00 | 0.00 | — |
Beneish M-Score |
(8.29) | (3.19) | (0.69) | (1.91) | (0.22) | — | — |
P/Operating CF |
(8.33) | 34.14 | (86.45) | (85.62) | (85.31) | (13.71) | — |
Dividend Safety Score |
45 | — | — | — | — | — | — |
P/B ratio |
0.69 | 1.38 | 1.75 | 2.68 | 3.31 | 2.18 | — |
Price to Tangible BV |
1.30 | 1.79 | 2.43 | 3.45 | 3.61 | 2.94 | — |
EV/Sales |
0.11 | 0.56 | 0.76 | 1.34 | 1.81 | 0.00 | — |
EV/EBITDA |
0.00 | 7.74 | 15.11 | 16.76 | 25.70 | 0.00 | — |
EV/Operating CF |
1.06 | 4.92 | (7.38) | 20.51 | (296.04) | 0.00 | — |
EV/FCF |
1.34 | 5.32 | (6.47) | 25.33 | (67.19) | 0.00 | — |
Quick Ratio |
2.13 | 2.46 | 1.89 | 2.60 | 4.39 | 2.44 | — |
Current Ratio |
2.26 | 2.50 | 1.99 | 2.71 | 4.42 | 2.49 | — |
Net Debt/EBITDA |
0.49 | (2.00) | (1.88) | (4.42) | (7.77) | 3.44 | — |
Debt/Assets |
0.08% | 0.00% | 0.01% | 0.31% | 0.42% | 0.59% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | — |
Asset Turnover |
0.96 | 1.30 | 1.41 | 1.25 | 1.56 | 1.88 | — |
Operating CF/Net income |
(0.19) | 3.51 | (9.40) | 0.83 | (0.08) | 0.74 | — |
Capex/Depreciation |
(0.10) | (0.34) | (0.55) | (0.41) | (0.94) | (1.10) | — |
Interest Coverage |
(143.32) | 14.87 | (8.94) | (28.62) | 20.13 | (72.13) | — |
| (82.71%) | 6.45% | 2.35% | 13.67% | 16.15% | (10.46%) | — | |
| (54.23%) | 4.23% | 1.55% | 9.84% | 11.59% | (28.67%) | — | |
ROIC |
(148.29%) | 7.94% | 3.83% | 11.11% | 18.17% | (26.26%) | — |
Return on Tangible Assets |
(183.38%) | 10.12% | 3.70% | 18.00% | 11.26% | (32.61%) | — |
Average Days of Receivables |
105.23 | 124.85 | 153.23 | 85.34 | 89.77 | 96.42 | — |
Research and Development Expense of Revenue |
4.21% | 1.88% | 1.74% | 1.22% | 1.04% | 1.26% | — |
Selling, General and Administrative Expense of Revenue |
41.86% | 22.75% | 22.42% | 24.55% | 24.99% | 37.90% | — |
Intangible Assets out of Total Assets |
0.00 | 0.16 | 0.17 | 0.16 | 0.06 | 0.17 | 0.00 |
Share Based Compensation of Revenue |
5.41% | 2.21% | 3.36% | 1.83% | 0.43% | 0.73% | — |
Graham Net Nets |
0.70 | 0.38 | 0.29 | 0.21 | 0.23 | 0.17 | — |
Graham Number |
0.00 | 3.63 | 2.15 | 4.72 | 9.15 | 0.00 | — |
Earnings Yield |
(210.23%) | 4.48% | 1.35% | 4.87% | 14.08% | (0.10%) | — |
Free Cash Flow Yield |
31.22% | 14.92% | (13.75%) | 3.12% | (1.14%) | 0.00% | — |
Revenue per Share |
3.25 | 6.02 | 6.03 | 4.35 | 3.97 | 1.61 | — |
Operating CF per Share |
0.35 | 0.68 | (0.62) | 0.29 | (0.02) | (0.18) | — |
Capex per Share |
(0.07) | (0.05) | (0.09) | (0.05) | (0.08) | (0.10) | — |
Free Cash Flow per Share |
0.27 | 0.63 | (0.71) | 0.23 | (0.11) | (0.29) | — |
Cash per Share |
0.52 | 0.87 | 0.57 | 1.55 | 2.19 | 0.56 | — |
Shareholders Equity per Share |
1.27 | 3.08 | 2.95 | 2.76 | 2.83 | 1.15 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.27 | 3.08 | 2.95 | 2.76 | 2.83 | 1.15 | — |
Free Cash Flow |
27.22 | 64.78 | (73.60) | 23.38 | (8.58) | (16.69) | — |
Working Capital |
84.91 | 182.68 | 168.75 | 170.92 | 198.16 | 34.93 | — |
Capital Expenditures |
(7.23) | (5.34) | (9.11) | (5.49) | (6.63) | (6.04) | — |
Net Current Asset Value |
61.17 | 164.04 | 153.59 | 156.73 | 173.49 | 25.20 | — |
EV/EBIT |
0.00 | 12.02 | 31.61 | 27.12 | 37.54 | 0.00 | — |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.06 | — |
Price to Operating Income |
0.00 | 15.13 | 35.55 | 34.27 | 48.89 | 0.00 | — |
| Other line items | |||||||
Depreciation/Fixed assets |
5.08 | 1.07 | 0.98 | 0.63 | 0.56 | 0.60 | — |
Cash ROIC |
15.37% | 16.02% | (20.19%) | 5.34% | (2.12%) | (16.70%) | — |
Accounts Receivable Turnover |
2.12 | 2.61 | 3.42 | 4.86 | 6.17 | 1.82 | — |
Accounts Payable Turnover |
11.32 | 16.73 | 20.72 | 15.28 | 21.12 | 6.34 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
18.15 | 25.68 | 16.87 | 27.56 | 27.66 | 23.00 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
151.90 | 236.49 | 182.54 | 90.69 | 51.62 | 51.62 | — |
Average Payables |
19.73 | 24.09 | 20.71 | 18.71 | 9.89 | 9.89 | — |
Average Assets |
336.36 | 473.04 | 441.86 | 351.44 | 204.89 | 50.09 | — |
Average Common Equity |
220.53 | 310.18 | 292.05 | 252.99 | 147.00 | 137.29 | — |
Columns are period end dates